Status:
RECRUITING
Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation
Lead Sponsor:
Cathreine BV
Collaborating Sponsors:
Medtronic
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
To achieve optimal long-term clinical results after percutaneous coronary intervention (PCI), adequate deployment of stents is essential. Thorough expansion of the stent and full apposition of stent s...
Detailed Description
The Netherlands Heart Registration (NHR) is an independent organization in which Dutch hospitals prospectively register standard sets of baseline, procedural and outcome data for all invasive cardiac ...
Eligibility Criteria
Inclusion
- All patients \>18 years old who undergo PCI for any indication are included in the register of the Netherlands Heart Registration and therefore included in the final analysis of this project
Exclusion
- \- If a patient has multiple PCIs within 365 days, only the first procedure is included.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT06558474
Start Date
September 1 2023
End Date
May 1 2026
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catharina Hospital
Eindhoven, North Brabant, Netherlands, 5623 EJ